skip to main content
Idioma:
Refinado por: data de publicação: 2005Até2012 remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials

Morgan, C ; Jin, X ; Yu, X ; De Rosa, S ; Kublin, J ; Metch, B ; Keefer, M ; NIAID, H

Retrovirology, 2012-09, Vol.9 (S2), p.P133-P133, Article P133 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Citações Citado por
2
Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)

Koblin, B ; Metch, B ; Morgan, C ; Novak, R ; Swann, E ; Metzger, D ; Lucy, D ; Dunbar, D ; Graham, P ; Madenwald, T ; Escamia, G ; Frank, I

Retrovirology, 2012-09, Vol.9 (S2), p.P123-P123, Article P123 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Citações Citado por
3
I133 The role of male circumcision in HIV prevention research
I133 The role of male circumcision in HIV prevention research
Material Type:
Artigo 		Adicionar ao Meu Espaço

I133 The role of male circumcision in HIV prevention research

Gray, G. ; De Bruyn, G. ; Mlisana, K. ; Metch, B. ; Kublin, J. ; Corey, L.

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S33-S33 [Periódico revisado por pares]

Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
4
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
Material Type:
Artigo 		Adicionar ao Meu Espaço

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

Gray, GE ; Bekker, L ; Churchyard, G ; Nchabeleng, M ; Mlisana, K ; de Bruyn, G ; Roux, S ; Mathebula, M ; Latka, M ; Bennie, T ; Metch, B ; Moodie, Z ; Allen, M ; Eaton, N ; Kublin, J

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P209-P209, Article P209 [Periódico revisado por pares]

BioMed Central Ltd

Texto completo disponível

Citações Citado por
5
P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
Material Type:
Artigo 		Adicionar ao Meu Espaço

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

Allen, MA ; Gray, G ; Churchyard, G ; Bekker, L ; Nchabeleng, M ; Mlisana, K ; Metch, B ; Moodie, Z ; Roux, S ; Mathebula, M ; Bennie, T ; Kublin, J

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P190-P190, Article P190 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Citações Citado por
6
P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial

de Bruyn, G ; Mlisana, K ; Metch, B ; Churchyard, G ; Nchabeleng, M ; Bekker, L ; Roux, S ; Naicker, N ; Latka, M ; Corey, L ; Kublin, J ; Gray, G

Retrovirology, 2009-10, Vol.6 (S3), p.P195-P195, Article P195 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Citações Citado por
7
Lessons From a Multisite International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120
Lessons From a Multisite International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lessons From a Multisite International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120

Cleghorn, Farley ; Pape, Jean W ; Schechter, Mauro ; Bartholomew, Courtenay ; Sanchez, Jorge ; Jack, Noreen ; Metch, Barbara J ; Hansen, Marianne ; Allen, Mary ; Cao, Huyen ; Montefiori, David C ; Tomaras, Georgia D ; Gurunathan, Sanjay ; Eastman, Donna J ; do Lago, Regina F ; Jean, Sonic ; Lama, Javier R ; Lawrence, Dale N ; Wright, Peter F

Journal of acquired immune deficiency syndromes (1999), 2007-10, Vol.46 (2), p.222-230 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins, Inc

Texto completo disponível

Citações Citado por
8
The HVTN Protocol 903 Vaccine Preparedness Study: Lessons Learned in Preparation for HIV Vaccine Efficacy Trials
The HVTN Protocol 903 Vaccine Preparedness Study: Lessons Learned in Preparation for HIV Vaccine Efficacy Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

The HVTN Protocol 903 Vaccine Preparedness Study: Lessons Learned in Preparation for HIV Vaccine Efficacy Trials

Djomand, Gaston ; Metch, Barbara ; Zorrilla, Carmen D ; Donastorg, Yeycy ; Casapia, Martin ; Villafana, Tonya ; Pape, Jean ; Figueroa, Peter ; Hansen, Marianne ; Buchbinder, Susan ; Beyrer, Chris

Journal of acquired immune deficiency syndromes (1999), 2008-05, Vol.48 (1), p.82-89 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins, Inc

Texto completo disponível

Citações Citado por
9
Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection
Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection

Flynn, Neil M ; Forthal, Donald N ; Harro, Clayton D ; Judson, Franklyn N ; Mayer, Kenneth H ; Para, Michael F

The Journal of infectious diseases, 2005-03, Vol.191 (5), p.654-665 [Periódico revisado por pares]

United States: The University of Chicago Press

Texto completo disponível

Citações Citado por
10
Safety and efficacy assessment of the HVTN 503/Phambili Study: A double-blind randomized placebo-controlled test-of-concept study of a Clade B-based HIV-1 vaccine in South Africa
Safety and efficacy assessment of the HVTN 503/Phambili Study: A double-blind randomized placebo-controlled test-of-concept study of a Clade B-based HIV-1 vaccine in South Africa
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy assessment of the HVTN 503/Phambili Study: A double-blind randomized placebo-controlled test-of-concept study of a Clade B-based HIV-1 vaccine in South Africa

Gray, GE ; Allen, M ; Moodie, Z ; Churchyard, G ; Bekker, L-G ; Nchabeleng, M ; Mlisana, K ; Metch, B ; de Bruyn, G ; Latka, MH ; Roux, S ; Mathebula, M ; Naicker, N ; Ducar, C ; Carter, DK ; Puren, A ; Eaton, N ; McElrath, MJ ; Robertson, M ; Corey, L ; Kublin, JG

The Lancet infectious diseases, 2011-05, Vol.11 (7), p.507-515 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2005  (1)
  2. 2005Até2006  (1)
  3. 2007Até2007  (1)
  4. 2008Até2009  (5)
  5. Após 2009  (5)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.